UN panel recommends stricter patentability rules and compulsory licensing to improve access to medicine

A United Nations taskforce released its much-anticipated report on patient access to medicines this week. In the run-up to the report’s publication, many IP owners expected that the role of patents in the drug industry would very much be in the…

Get unlimited access to all IAM content